IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q2 2014 Holdings

Filed 2014-07-30 | 4 holdings | $178.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals, Inc.(AGIO)COM00847X104$178.5M3,895,09099.8%
Foundation Medicine, Inc.COM350465100$132.8K4,927,2340.1%
bluebird bio, Inc.COM09609G100$93.2K2,416,9740.1%
Eleven Biotherapeutics, Inc.COM286221106$63.8K4,841,5910.0%